Medical therapy following hospitalization for heart failure with reduced ejection fraction and association with discharge to long-term care: a cross-sectional analysis of the REasons for Geographic And Racial Differences in Stroke (REGARDS) population

Table 4 Average percentage of target dose of medications^a among REGARDS participants hospitalized for HFrEF

HFrEF Heart failure with reduced ejection fraction, ACEI/ARB Angiotensin converting enzyme inhibitor or angiotensin receptor blocker
^aCalculated as the dose prescribed or filled of the specific agent divided by the target dose for that agent recommended in the 2013 American College of Cardiology/American Heart Association guideline for the management of heart failure
^bDetermined from review of medical records among those with the medication on their discharge medication
^cDetermined using Medicare pharmacy claims data among those with claims for the medication
^dCarvedilol, metoprolol succinate, or bisoprolol

ISSN: 1471-2261